Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)
The purpose of this Notice of Amendment is to notify about the additions of gemtuzumab ozogamacin, gilteritinib, icosapent ethyl, tafamidis, trifarotine and upadacitinib to the Prescription Drug List (PDL) for human and/or veterinary use.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)HTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Multiple Additions (2020-02-13)HTMLFrench publication HTML
Similar records